Similar Blog Posts

MOLCURE signs joint research agreement with Teijin Pharma to develop antibody drugs using AI-driven drug discovery platform technology, January 9

MOLCURE signs joint research agreement with Teijin Pharma to develop antibody drugs using AI-driven drug discovery platform technology, January 9

Read more
帝人ファーマとAI創薬プラットフォーム技術を活用した抗体医薬品の創製に関する共同研究契約を締結, January 9

帝人ファーマとAI創薬プラットフォーム技術を活用した抗体医薬品の創製に関する共同研究契約を締結, January 9

Read more
MOLCURE at Biotech Showcase 2025, January 13-15

MOLCURE at Biotech Showcase 2025, January 13-15

Read more
MOLCUREがBiotech Showcase 2025に参加, January 13-15

MOLCUREがBiotech Showcase 2025に参加, January 13-15

Read more